VKTX Viking Therapeutics Inc Total Business Assets
Viking Therapeutics (VKTX) is scaling the expansion of its innovative oral obesity treatment as it completes final testing. Fluctuations in total capital and liabilities on the GURU.Markets base chart have stabilized at 858.36. Asset growth is supported by an elite team of highly motivated scientists. Upon successful trials, Viking Therapeutics (VKTX) will gain immense pricing power within the diabetes treatment segment.
Analytical breakdowns and data insights for company Viking Pharma (VKTX)
- stock quotes and analyst forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Viking Therapeutics|VKTX - Long-Term Debt to Equity|Current Liabilities to Capital Viking Therapeutics Corp|VKTX - Company Total Debt|Debt to Book Capitalization Ratio Viking Therapeutics Corp|VKTX - Company Long-Term Debts|Short-Term Debt Volume Viking Therapeutics|Quick Ratio vikingtherapeutics.com
- company profitability and valuation multiples indicators:
Summary company analysis:vikingtherapeutics.com, VKTX
A reverse calculation of total assets via ROA eliminates the time lag of quarterly reporting, allowing for the real-time tracking of company resource dynamics. For Viking Therapeutics (VKTX), which operates on investment funding, the total assets chart reflects the efficiency of capital management required for the commercialization of GLP-1 drugs, which is critical for assessing financial stability prior to market entry.
Direct competitors
Total Business Assets BIIB|Aggregate Company Assets Neurocrine Biosciences, Inc.|Total Business Assets RGC (Regencell Bioscience Ltd)|Company Total Assets AXSM|ACAD - Company Assets|Xenon Pharmaceuticals - Cumulative Company Assets|Company Total Assets supernus.com SUPN|CPRX - Aggregate Company Assets|Aggregate Asset Value DNLI (Denali)|Harmony Pharma (HRMY) - Aggregate Company Assets|Company Assets Biohaven Corp (BHVN)|Cumulative Company Assets AMLX|Aggregate Company Assets TRVI|Company Total Assets PRAX|Company Total Asset Base Anavex|Aggregate Company Assets CeriBell Corp CBLL|Company Total Assets Prothena PRTA|Alector Therapeutics - Company Total Assets|Company Total Asset Base annexonbio.com ANNX|omeros.com (OMER) - Aggregate Company Assets|Total Business Assets NGNE|ACIU (AC Immune Corp) - Company Total Assets|VYGR - Company Balance Sheet Assets|Cumulative Company Assets NMRA (Neumora Therapeutics)|SCLX (scilexholding.com) - Aggregate Asset Value|Tevogen Bio - Cumulative Company Assets|Aggregate Business Assets ACOG (Alpha Cognition Inc)|Cognition Therapeutics, Inc. - Company Total Assets|Aggregate Asset Value IKT (Inhibikase Pharma)|SAVA: Company Total Assets|Company Assets Assertio (ASRT)|Aggregate Company Assets Coya Therapeutics Inc|VTGN: Aggregate Asset Value|Company Total Assets OVID|Company Total Assets Acumen Pharmaceuticals, Inc (ABOS)|Aggregate Company Assets CervoMed Inc. CRVO|ATHE (Alterity Therapeutics Ltd.) - Total Asset Value of Company|Clene Nanomedicine - Company Total Assets|Company Assets PepGen Inc.|JUNS (Jupiter Neurosciences) - Cumulative Company Assets|Relmada Corp (RLMD) - Company Total Assets|Cumulative Company Assets ANVS|GRCE (Grace Tx) - Aggregate Business Assets|Company Total Assets AIFF|Company Total Asset Base anewmeds.com|Company Total Assets NRSN (NeuroSense Therapeutics Ltd.)|RVPH - Cumulative Company Assets|MTVA - Aggregate Company Assets|Company Total Asset Base neuraxis.com NRXS|HSDT (heliusmedical.com) - Cumulative Company Assets|PASG (Passage Bio) - Aggregate Company Assets|Aggregate Company Assets Neuphoria Therapeutics, Inc.|Company Total Assets Minerva|Cumulative Company Assets ATHA (Athira Pharma, Inc.)|Aggregate Business Assets ADXN|Alzamend Neuro - Cumulative Company Assets|CYCN: Total Business Assets|PTIX - Aggregate Company Assets|KTTA (Pasithea Therapeutics) - Total Business Assets|CRGT: Company Total Assets|Company Assets avenuetx.com (ATXI)|Cumulative Company Assets BCLI|Company Total Assets Cara Therapeutics Inc.|Aggregate Company Assets Chromocell Therapeutics Corporation (CHRO)|ELYM (eliemtx.com) - Aggregate Asset Value|Aggregate Company Assets Intra-Cellular Therapies, Inc. ITCI|longboardpharma.com (LBPH) - Company Assets|MRNS: Cumulative Company Assets|NKGN: Aggregate Company Assets|NRBO: Company Total Assets|SAGE - Company Total Asset Base|Aggregate Company Assets Synaptogenix, Inc.|Company Total Assets trevena.com|Company Total Assets VIGL|Company Total Asset Base anewmeds.com|Aggregate Company Assets Cerevel CERE